VELA Investment Management LLC Decreases Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

VELA Investment Management LLC decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 38.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,101 shares of the medical instruments supplier’s stock after selling 31,019 shares during the quarter. VELA Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $932,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $27,000. Kennebec Savings Bank purchased a new stake in DENTSPLY SIRONA in the 3rd quarter valued at approximately $35,000. MassMutual Private Wealth & Trust FSB lifted its stake in DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares in the last quarter. Finally, Van ECK Associates Corp purchased a new stake in DENTSPLY SIRONA in the 3rd quarter valued at approximately $42,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on XRAY shares. UBS Group reduced their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Mizuho started coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Barrington Research reduced their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Finally, Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th. Ten investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $24.50.

DENTSPLY SIRONA Trading Down 8.8 %

XRAY stock opened at $17.15 on Friday. The company has a market cap of $3.41 billion, a price-to-earnings ratio of -8.28, a PEG ratio of 1.80 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a fifty day simple moving average of $18.90 and a 200-day simple moving average of $21.58. DENTSPLY SIRONA Inc. has a 52 week low of $17.09 and a 52 week high of $34.91.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.73%. DENTSPLY SIRONA’s payout ratio is -30.92%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.